Skip to content

The comparative of Poulk vaginal gel and metronidazole vaginal gel effect on treatment of bacterial vaginosis

The comparative of Poulk vaginal gel and metronidazole vaginal gel effect on treatment of bacterial vaginosis in Vaginosis patients : A Double Blind Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201201049560N1
Enrollment
112
Registered
2021-02-15
Start date
2021-05-12
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginosis. Other specified inflammation of vagina and vulva

Interventions

Intervention 1: 5% vaginal gel, 50 g, 7 days, 1 applicator 5 g every night while sleeping inside the vagina. Extraction(Extraction of plant leaves using soaking method and using 80% aqueous solutions)

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: willingness to cooperate positive Whiff test signs of bacterial vaginosis in examination Positive cluecell

Exclusion criteria

Exclusion criteria: Multi partner Stricken to specific diseases like liver diseases ,kidney diseases and central chords system diseases ,blood dyscrasi ,diabetes ,impair of safety system Having abnormal uterus bleeding Frequently vulvovaginits pregnancy Mensturation Lactating Use of vaginal douches frequently, consuming remedy for treatment in 3 recent months Consumig alcohol and anti coagulation remedies and recent consuming anti-parasite remedy, anti-biotic, weakening remedy of safety system and vaginalis remedy President of allergy in using metronidazol tablet consuming remedy for treatment in 3 recent months

Design outcomes

Primary

MeasureTime frame
Bacterial Vaginosis. Timepoint: Before treatment and after treatment. Method of measurement: Based on the criteria of Amsell (Evaluation of vaginal discharge in terms of odor, color and presence of key cells with the emphasis on emphasis) and Nugent.

Secondary

MeasureTime frame
Vaginal discharge. Timepoint: 14-28 days after treatment. Method of measurement: Observation.;The acidity of vagina. Timepoint: 14-28 days after treatment. Method of measurement: PH strip.;Whiff test. Timepoint: 14-28 days after treatment. Method of measurement: Potassium hydroxide solution 10%.;Clue cells. Timepoint: 14-28 days after treatment. Method of measurement: Evaluation of clue cells on the wet lam.;Sexual Fanction score. Timepoint: Before and 14 days after treatment. Method of measurement: Rosen Sexual Function Questionnaire.;Sexual Satisfaction score. Timepoint: Before and 14 days after treatment. Method of measurement: Larson Sexual Satisfaction Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Iravani

Ahvaz University of Medical Sciences

minairavani2004@yahoo.com+98 61 3373 8331

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026